Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Bayer to Acquire Perfuse Therapeutics for Up to $2.45B

Lucid Diligence Brief: Bayer to Acquire Perfuse Therapeutics for Up to $2.45B…


Cardiovascular

Cardiovascular Today—April 23, 2026

This week’s Cardiovascular update highlights regulatory clearances, late-stage…


Cardiovascular

Cardiovascular Today—April 16, 2026

This week’s Cardiovascular update highlights regulatory approvals, pivotal…


Cardiovascular

Cardiovascular Video Recap—February 12, 2026

This biweekly Cardiovascular Video Recap covers late-stage clinical data,…


Cardiovascular

Cardiovascular Today—Februrary 12, 2026

This weekly Cardiovascular update covers clinical progress, guideline changes,…


Cardiovascular

Cardiovascular Video Recap—January 29, 2026

This biweekly Cardiovascular Video Recap reviews regulatory actions, late-stage…


Cardiovascular

Cardiovascular Today—January 22, 2026

This Cardiovascular weekly update covers significant advancements in…


Oncology News

Oncology Video Recap—January 19, 2026

In this week's Oncology update regulatory milestones and late-stage clinical…


Vaccines_News

Vaccines Video Recap—January 9, 2026

This Vaccines video recap covers major vaccine and immunization developments,…


Vaccines

Vaccines Today—January 9, 2026

This vaccines update highlights key vaccine developments spanning early…


Cardiovascular

Cardiovascular Video Recap—December 4, 2025

This Cardiovascular Video Recap covers mechanistic trial wins, national…


Cardiovascular

Cardiovascular Today—December 4, 2025

This week’s cardiovascular update brings together new clinical signals, imaging…


Privacy Preference Center